Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
Dinaqor
8952 Schlieren, Wagistrasse 25
DiNAQOR’s mission is to develop gene therapy solutions that transform the lives of patients with heart disease. Our novel and innovative gene therapy platform is focused on advancing treatments for patients affected by genetic cardiomyopathies, a disease of the heart muscle that can lead to heart failure.
Dinaqor
Wagistrasse 25
8952 Schlieren
evitria AG
8951 Fahrweid, Brunaustrasse 185
evitria is specialized in CHO-based transient expression of antibodies (including bispecific and fusion antibodies). With a track record of more than 50,000 transfections performed and more than 9,000 antibodies expressed and purified for our clients, we can offer fast and reliable project execution at high quality standards (all production facilities in Switzerland) and affordable prices. Transfections are made with serum-free, animal-component free reagents at a monthly capacity of up to 500 liters. You can benefit from our expertise and unique focus when looking to entrust a partner with your complete antibody production or to manage capacity bottlenecks with single projects.
evitria AG
Brunaustrasse 185
8951 Fahrweid
The Mobility House AG
8005 Zürich, Technoparkstrasse 1 / Pauli 4001 (c/o itopia ag - corporate information technology)
+41 43 508 18 91
office_ch@mobilityhouse.com
Die Energiewende vorantreiben, eine emissionsfreie Zukunft ermöglichen - The Mobility House verhilft mit intelligenten Lade- und Energiespeicher-Lösungen der Elektromobilität zum Durchbruch.
The Mobility House AG
Technoparkstrasse 1
8005 Zürich
5 Ergebnisse für "gene" unter The Mobility House AG
ETH Zürich - Numerische Materialmodellierung
8005 Zürich, Technoparkstrasse 1 / Einstein PFA G 11 (2. OG)
ETH Zürich - Numerische Materialmodellierung
Technoparkstrasse 1
8005 Zürich
Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
3 Ergebnisse für "gene" unter Roche Glycart AG
Molekylärbiologiska analyser rekommenderas för detektion av sars-CoV-2
... ® Modular SARS-CoV-2 (COVID19) N- gene, Roche Diagnostics article no. 09155350001. 2020-02-11 World health ... -CoV-2 (COVID19) N- gene, Roche Diagnostics article no. 09155350001. 2020-02-11 World health ...
Test faktorů II a V cobas® ️Factor II and Factor V Test
... Genet. 2012;81(1):7-17. Dziadosz M, Baxi LV. Global prevalence of prothrombin gene mutation G20210A and ... LV. Global prevalence of prothrombin gene mutation G20210A and implications in women’s health: a ...
University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
ETH Zürich - Feasibility Lab
Technoparkstrasse 1
8005 Zürich